LEO PHARMA A/S Financials, key figures and credit report
Net sales 13 499.0 mDKK FY 2025 +8.4% vs 2024
EBIT margin 16.9 % FY 2025 +26.1 pp vs 2024
Net debt 9 185.0 mDKK FY 2025 -14.7% vs 2024
Quick ratio 0.7 FY 2025 +0.1 vs 2024
Income statement (mDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 9 957.00 | 10 641.00 | 11 392.00 | 12 453.00 | 13 499.00 |
| Other operating income | 62.00 | 73.00 | 41.00 | 13.00 | 1 741.00 |
| Costs of manufacturing | -3 962.00 | -4 358.00 | -4 192.00 | -4 935.00 | -5 259.00 |
| Gross profit | 5 995.00 | 6 283.00 | 7 200.00 | 7 518.00 | 8 240.00 |
| Costs of management | -2 390.00 | -2 407.00 | -1 720.00 | -1 482.00 | -1 350.00 |
| Other operating expenses | -7 823.00 | -7 260.00 | -7 220.00 | -7 192.00 | -6 352.00 |
| EBIT | -4 156.00 | -3 311.00 | -1 699.00 | -1 143.00 | 2 279.00 |
| Other financial income | 19.00 | 3.00 | 47.00 | 132.00 | 122.00 |
| Other financial expenses | - 626.00 | - 785.00 | -1 140.00 | - 946.00 | - 688.00 |
| Pre-tax profit | -4 763.00 | -4 093.00 | -2 792.00 | -1 957.00 | 1 713.00 |
| Income taxes | - 105.00 | -17.00 | - 815.00 | 181.00 | 776.00 |
| Net earnings | -4 868.00 | -4 110.00 | -3 607.00 | -1 776.00 | 2 489.00 |
Assets (mDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible rights | 8 462.00 | 7 463.00 | 6 099.00 | 4 558.00 | 4 356.00 |
| Goodwill | 192.00 | 192.00 | 192.00 | 192.00 | |
| Intangible assets total | 8 654.00 | 7 655.00 | 6 099.00 | 4 750.00 | 4 548.00 |
| Buildings | 951.00 | 938.00 | |||
| Machinery and equipment | 963.00 | 899.00 | |||
| Advance payments and construction in progress | 2 373.00 | 2 694.00 | |||
| Other tangible assets | 176.00 | 177.00 | 4 516.00 | 4 445.00 | 4 367.00 |
| Tangible assets total | 4 463.00 | 4 708.00 | 4 516.00 | 4 445.00 | 4 367.00 |
| Other non-current investments | 540.00 | 593.00 | 500.00 | 800.00 | 756.00 |
| Investments total | 540.00 | 593.00 | 500.00 | 800.00 | 756.00 |
| Deferred tax assets | 1 453.00 | 1 809.00 | 1 157.00 | 1 482.00 | 2 491.00 |
| Long term receivables total | 1 453.00 | 1 809.00 | 1 157.00 | 1 482.00 | 2 491.00 |
| Inventories total | 3 869.00 | 4 580.00 | 4 866.00 | 4 973.00 | 4 050.00 |
| Current trade debtors | 2 254.00 | 2 136.00 | 2 142.00 | 2 368.00 | 3 041.00 |
| Prepayments and accrued income | 360.00 | 289.00 | |||
| Current other receivables | 571.00 | 658.00 | 910.00 | 553.00 | 620.00 |
| Current deferred tax assets | 1 099.00 | 234.00 | 545.00 | 553.00 | 337.00 |
| Short term receivables total | 4 284.00 | 3 317.00 | 3 597.00 | 3 474.00 | 3 998.00 |
| Cash and bank deposits | 432.00 | 270.00 | 216.00 | 227.00 | 235.00 |
| Cash and cash equivalents | 432.00 | 270.00 | 216.00 | 227.00 | 235.00 |
| Balance sheet total (assets) | 23 695.00 | 22 932.00 | 20 951.00 | 20 151.00 | 20 445.00 |
Equity and liabilities (mDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 320.00 | 321.00 | 383.00 | 383.00 | 384.00 |
| Other reserves | - 313.00 | - 107.00 | - 183.00 | - 370.00 | - 326.00 |
| Retained earnings | 10 398.00 | 5 842.00 | 7 932.00 | 4 467.00 | 2 715.00 |
| Profit of the financial year | -4 868.00 | -4 110.00 | -3 607.00 | -1 776.00 | 2 489.00 |
| Shareholders equity total | 5 537.00 | 1 946.00 | 4 525.00 | 2 704.00 | 5 262.00 |
| Non-current loans from credit institutions | 8 928.00 | 13 764.00 | 10 404.00 | 10 414.00 | 8 470.00 |
| Non-current leasing loans | 381.00 | 317.00 | 238.00 | 164.00 | 168.00 |
| Non-current pension loans | 284.00 | 71.00 | 77.00 | 75.00 | 61.00 |
| Provisions | 352.00 | 290.00 | 131.00 | 307.00 | 295.00 |
| Non-current other liabilities | 322.00 | 175.00 | 461.00 | 464.00 | 285.00 |
| Non-current deferred tax liabilities | 490.00 | 528.00 | 160.00 | 102.00 | 76.00 |
| Non-current liabilities total | 10 757.00 | 15 145.00 | 11 471.00 | 11 526.00 | 9 355.00 |
| Current loans from credit institutions | 1 341.00 | 407.00 | 265.00 | 502.00 | 889.00 |
| Current leasing loans | 121.00 | 125.00 | 87.00 | 82.00 | 66.00 |
| Current trade creditors | 1 619.00 | 1 302.00 | 1 243.00 | 1 440.00 | 1 017.00 |
| Short-term deferred tax liabilities | 538.00 | 515.00 | 285.00 | 112.00 | 173.00 |
| Other non-interest bearing current liabilities | 2 892.00 | 2 513.00 | 2 150.00 | 2 621.00 | 2 703.00 |
| Current provisions | 890.00 | 979.00 | 925.00 | 1 164.00 | 980.00 |
| Current liabilities total | 7 401.00 | 5 841.00 | 4 955.00 | 5 921.00 | 5 828.00 |
| Balance sheet total (liabilities) | 23 695.00 | 22 932.00 | 20 951.00 | 20 151.00 | 20 445.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated